Get the latest Science News and Discoveries
Arena Pharmaceuticals presents clinician and patient reported outcomes data from phase 2b ADVISE trial evaluating etrasimod in adult atopic dermatitis during a late-breaking session at American Academy of Dermatology VMX
None
Or read this on Eureka Alert